MAPK1 and Sepsis: As the inhibitors of BET proteins [10] and MEK1/2 kinase [16] have already been shown to ameliorate sepsis in in vivo models, and no such studies were performed with ERK inhibitors, we focused on SCH772984 that inhibited TNFa production in vitro.